Schedule 13G ownership disclosure

ONCTERNAL THERAPEUTICS INC

Security class unavailable · CUSIP: 68236P107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,864,140
Percent of class
5.0800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-016633
Form type
SC 13G
Filer
Oncternal Oncology, Inc.
CIK
CIK 1600987
Filed
Feb 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub